Drugs that contain Ganciclovir
1. Ganzyk-rtu patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9486530 | EXELA PHARMA | Ganciclovir compositions and related methods |
Sep, 2034
(10 years from now) | |
Market Authorisation Date: 17 February, 2017
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
GANZYK-RTU family patents
